FDA — authorised 10 May 1961
- Marketing authorisation holder: ABBVIE
- Status: approved
🇺🇸 Alvinol in United States
FDA authorised Alvinol on 10 May 1961
Marketing authorisations
FDA — authorised 10 May 1961
- Application: NDA010021
- Marketing authorisation holder: ABBVIE
- Local brand name: PLACIDYL
- Indication: CAPSULE — ORAL
- Status: approved
Alvinol in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Alvinol approved in United States?
Yes. FDA authorised it on 10 May 1961; FDA authorised it on 10 May 1961.
Who is the marketing authorisation holder for Alvinol in United States?
ABBVIE holds the US marketing authorisation.